# US 2016/0256315 A1 · Medicament delivery devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256315 A1
- Document ID: US20160256315A1
- Status: Published application
- Kind: A1
- Application number: 15/156,999
- Filed: 2016-05-17
- Published: 2016-09-08
- Earliest claimed: 2015-02-10
- Assignees: Omega Ophthalmics LLC
- Applicants: Omega Ophthalmics LLC
- Inventors: Gary N. Wortz; Rick William Ifland
- Web page: https://patentgrep.com/patent/US20160256315A1

## CPC

- A61F 2/14: Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F 2/16: Intraocular lenses
- A61F 2/1648: {Multipart lenses}
- A61F 2/1691: {Packages or dispensers for intraocular lenses (for contact lenses A45C11/005)}
- A61F 2/1694: {Capsular bag spreaders therefor}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61F 2002/1681: {having supporting structure for lens, e.g. haptics}
- A61F 2002/1689: {having plate-haptics}
- A61F 2002/169: {Surrounding optic}
- A61F 2002/16901: {Supporting structure conforms to shape of capsular bag}
- A61F 2002/16902: {Separable from intraocular lens}
- A61F 2210/0014: using shape memory or superelastic materials, e.g. nitinol
- A61F 2220/0033: made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
- A61F 2220/0075: sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
- A61F 2250/0068: the pharmaceutical product being in a reservoir
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A prosthetic capsular device configured to be inserted in an eye includes a housing structure and a ring structure. The housing structure includes a first side, a second side opposite the first side, a third side, a fourth side opposite the third side, a posterior side including a refractive surface, an anterior side opposite the posterior side, and a longitudinal axis. The first side, the second side, the third side, the fourth side, the posterior side, and the anterior side at least partially define a cavity configured to contain an intraocular device (e.g., an IOL). The anterior side includes an opening. The ring structure includes a ring structure portion extending radially outward from proximate one of an end of the first side and an end of the second side.

## Claims

### Claim 1

A medicament delivery device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
an anterior side;
a posterior side;
a framework comprising a flexible material capable of reverting to an original shape upon insertion in a cavity of a prosthetic capsular device in an eye, the framework comprising a ring proximate to the anterior side, the ring comprising:
a first straight portion, the first straight portion including:
a first end, and
a second end,
a second straight portion, the second straight portion including:
a first end, and
a second end,
a third arcuate portion extending between the first end of the first straight portion and the first end of the second straight portion, and
a fourth arcuate portion extending between the second end of the first straight portion and the second end of the second straight portion,
at least one of the first straight portion, the second straight portion, the third arcuate portion, and the fourth arcuate portion comprising a break in the flexible material;
a first cage coupled to at least the third arcuate portion of the framework, the first cage extending between the anterior side and the posterior side, the first cage configured to contain a first medicament, the first cage comprising a mesh structure configured to allow the first medicament to interact with anterior chamber fluid of an eye; and
a second cage coupled to at least the fourth arcuate portion of the framework, the second cage extending between the anterior side and the posterior side, the second cage configured to contain a second medicament, the second cage comprising a mesh structure configured to allow the second medicament to interact with anterior chamber fluid of an eye,
the framework, the first cage, and the second cage configured to be radially outward of a visual axis of an eye in a cavity of a prosthetic capsular device.

### Claim 2 (depends on 1)

The device of claim 1, wherein at least one of the first cage and the second cage comprises an opening or slit configured to allow insertion or removal of the first or second medicament after insertion in a cavity of a prosthetic capsular device.

### Claim 3 (depends on 1)

The device of claim 1, wherein the first medicament is different than the second medicament.

### Claim 4 (depends on 1)

A system configured to be inserted in a natural capsular bag of an eye after removal of a lens, the system comprising:
ice of claim 1; and
a prosthetic capsular device, the prosthetic capsular device comprising:
a first straight lateral side,
a second straight lateral side,
a third arcuate lateral side,
a fourth arcuate lateral side,
a posterior side,
an anterior side,
the first straight lateral side, the second straight lateral side, the third arcuate lateral side, the fourth arcuate lateral side, the posterior side, and the anterior side at least partially defining a cavity, the cavity having a lateral shape corresponding to a lateral shape of the framework,
wherein the device of claim 1 is configured to be inserted into the cavity of the prosthetic capsular device.

### Claim 5

A medicament delivery device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
an anterior side;
a posterior side;
a framework comprising a flexible material capable of reverting to an original shape upon insertion in a cavity of a prosthetic capsular device in an eye, the framework comprising a ring, the ring comprising:
a first straight portion, the first straight portion including:
a first end, and
a second end,
a second straight portion, the second straight portion including:
a first end, and
a second end,
a third arcuate portion extending between the first end of the first straight portion and the first end of the second straight portion, and
a fourth arcuate portion extending between the second end of the first straight portion and the second end of the second straight portion;
a cage coupled to at least the third arcuate portion of the framework, the cage extending between the anterior side and the posterior side, the cage configured to contain a medicament.

### Claim 6 (depends on 5)

The device of claim 5, wherein the ring is proximate to the anterior side.

### Claim 7 (depends on 5)

The device of claim 5, wherein at least one of the first straight portion, the second straight portion, the third arcuate portion, and the fourth arcuate portion comprises a break in the flexible material.

### Claim 8 (depends on 5)

The device of claim 5, wherein the cage comprises a mesh structure configured to allow the medicament to interact with anterior chamber fluid of an eye.

### Claim 9 (depends on 5)

The device of claim 5, wherein the cage comprises a selective membrane configured to allow the medicament to flow out of the cage.

### Claim 10 (depends on 5)

The device of claim 5, wherein the cage comprises an opening or slit configured to allow insertion or removal of the medicament after insertion in a cavity of a prosthetic capsular device.

### Claim 11 (depends on 5)

The device of claim 5, further comprising a second cage coupled to at least the fourth arcuate portion of the framework, the second cage configured to contain a second medicament.

### Claim 12 (depends on 6)

A system configured to be inserted in a natural capsular bag of an eye after removal of a lens, the system comprising:
ice of claim 6; and
a prosthetic capsular device, the prosthetic capsular device comprising:
lateral sides,
a posterior side,
an anterior side,
the lateral sides, the posterior side, and the anterior side at least partially defining a cavity, the cavity having a lateral shape corresponding to a lateral shape of the framework,
wherein the device of claim 6 is configured to be inserted into the cavity of the prosthetic capsular device.

### Claim 13

A medicament delivery device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
an anterior side;
a posterior side;
a framework comprising a flexible material capable of reverting to an original shape upon insertion in a cavity of a prosthetic capsular device in an eye; and
a cage coupled to the framework, the cage extending between the anterior side and the posterior side, the cage configured to contain a medicament.

### Claim 14 (depends on 13)

The device of claim 13, wherein the cage comprises a mesh structure configured to allow the medicament to interact with anterior chamber fluid of an eye.

### Claim 15 (depends on 13)

The device of claim 13, wherein the cage comprises a selective membrane configured to allow the medicament to flow out of the cage.

### Claim 16 (depends on 13)

The device of claim 13, wherein the framework comprises a ring proximate to the anterior side.

### Claim 17 (depends on 16)

The device of claim 16, wherein the ring comprises a break in the flexible material.

### Claim 18 (depends on 13)

The device of claim 13, wherein the framework comprises a plurality of rings.

### Claim 19 (depends on 13)

The device of claim 13, wherein the flexible material comprises at least one of polyimide, polyamide, PLLA, PLGA, and superelastic alloy.

### Claim 20 (depends on 13)

The device of claim 13, wherein the cage is coupled to the framework by at least one of adhesive, welding, chemical adhesion, intertwining, and threading part of the framework through a sleeve.

### Claim 21 (depends on 13)

The device of claim 13, wherein the cage comprises an opening or slit configured to allow insertion or removal of medicament after insertion in a cavity of a prosthetic capsular device.

### Claim 22 (depends on 13)

The device of claim 13, further comprising a second cage coupled to the framework, the second cage configured to contain a second medicament.

### Claim 23 (depends on 22)

The device of claim 22, wherein the medicament is different than the second medicament.

### Claim 24 (depends on 13)

The device of claim 13, wherein the medicament comprises a bacterial culture configured to derive nutrients from anterior chamber fluid of an eye and to provide a protein as a waste product.

### Claim 25 (depends on 13)

A system configured to be inserted in a natural capsular bag of an eye after removal of a lens, the system comprising:
the medicament delivery device of claim 13; and
a prosthetic capsular device, the prosthetic capsular device comprising a cavity having a lateral shape corresponding to a lateral shape of the framework,
the device of claim 13 is configured to be inserted into the cavity of the prosthetic capsular device.

### Claim 26 (depends on 25)

The system of claim 25, wherein the prosthetic capsular device comprises an anterior opening, and wherein the medicament delivery device is configured to be radially outward of the anterior opening upon insertion of the prosthetic capsular device in the cavity of the prosthetic capsular device.

### Claim 27 (depends on 25)

The system of claim 25, wherein the prosthetic capsular device comprises a posterior refractive optic, and wherein the medicament delivery device is configured to be radially outward of the posterior refractive optic upon insertion of the prosthetic capsular device in the cavity of the prosthetic capsular device.

### Claim 28 (depends on 25)

The system of claim 25, wherein the prosthetic capsular device comprises features configured to interact with the medicament delivery device.
